Table 2.
Summary of Primary Outcome Measures
| 6-Week Time Point
|
12-Week Time Point
|
|||
|---|---|---|---|---|
| GBR | TRC | GBR | TRC | |
| Linear bone height (%) | ||||
| Mean | 55.3 | 78.9 | 74.6 | 80.1 |
| Mean diff GBR & TRC | 23.6 | 5.4 | ||
| 95% CI | 6.02, 41.09 | −12.11, 22.95 | ||
| p value | 0.01 | 0.28 | ||
| Bone volume fraction (BVF) | ||||
| Mean | 0.13 | 0.28 | 0.24 | 0.30 |
| Mean diff GBR & TRC | 0.15 | 0.05 | ||
| 95% CI | −0.03, 0.34 | −0.14, 0.24 | ||
| p value | 0.07 | 0.30 | ||
| Bone mineral density (BMD, mg/cc) | ||||
| Mean (mg/cc) | 85.5 | 195.0 | 146.6 | 186.8 |
| Mean diff GBR & TRC | 109.5 | 40.2 | ||
| 95% CI | −28.6, 247.5 | −97.8, 178.3 | ||
| p value | 0.08 | 0.29 | ||
| Bone area/tissue area (BA/TA) | ||||
| Mean | 0.196 | 0.335 | 0.351 | 0.352 |
| Mean diff GBR & TRC | 0.139 | 0.002 | ||
| 95% CI | −0.053, 0.332 | −0.191, 0.194 | ||
| p value | 0.09 | 0.49 | ||